The announcement came after the Slovak State Institute for Drug Control concluded last week that the death of a 47-year-old woman who received the AstraZeneca was “likely” related to the vaccine.
Millions of doses of AstraZeneca have been given safely in Europe, however concerns remain about a rare type of blood clot that has been seen in an extremely small number of recipients.
AstraZeneca continues to be given to those in Slovakia who have waiting for their second shot.
The Ministry of Health said it was considering its next steps and would inform the public later in the week.
Denmark and Norway, two European countries that have been very careful with all vaccines, are using AstraZeneca not in their vaccination programs.